Upneeq Solution/ Drops
NDC Package 73687-062-34

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Upneeq (oxymetazoline hydrochloride ophthalmic) solution/ dropses is uPNEEQ is indicated for the treatment of acquired blepharoptosis in adults. This formulation utilizes a solution/ drops delivery system. Marketed by Rvl Pharmaceuticals, Inc., this product is identified by NDC 73687-062 and is authorized under FDA application NDA212520.

Identification & Billing

NDC Package Code
73687-062-34
Package Description
30 AMPULE in 1 CARTON / .3 mL in 1 AMPULE (73687-062-80)
Product Code
73687-062
11-Digit Billing Format
73687006234
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Upneeq
Non-Proprietary Name
Oxymetazoline Hydrochloride Ophthalmic
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE 1 mg/mL
Pharmacologic Class
Usage Information
UPNEEQ is indicated for the treatment of acquired blepharoptosis in adults.

Regulatory & Marketing

Labeler Name
Rvl Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA212520
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-21-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73687-062). Click a package code to view its specific billing and regulatory data.

73687-062-25
15 AMPULE in 1 CARTON / .3 mL in 1 AMPULE (73687-062-80)
73687-062-32
30 AMPULE in 1 CARTON / .3 mL in 1 AMPULE (73687-062-70)
73687-062-45
45 AMPULE in 1 CARTON / .3 mL in 1 AMPULE (73687-062-70)
73687-062-68
5 AMPULE in 1 CARTON / .3 mL in 1 AMPULE (73687-062-80)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73687-062-34 identifies a specific commercial package of 30 ampule in 1 carton / .3 ml in 1 ampule (73687-062-80) of Upneeq, a human prescription drug labeled by Rvl Pharmaceuticals, Inc.. This solution/ drops is formulated for ophthalmic use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rvl Pharmaceuticals, Inc. on August 21, 2020. The current certification is valid through December 31, 2026.

How is this Rvl Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73687006234. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73687-062-34
11-Digit CMS (5-4-2)
73687-0062-34

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.